|
[1] NAKAI Y,ISAYAMA H,WANG HP,et al. International consensus statements for endoscopic management of distal biliary stricture[J]. J Gastroenterol Hepatol,2019.[Online ahead of print]
|
|
[2] SHEKELLE PG,WOOLF SH,ECCLES M,et al. Developing clinical guidelines[J]. West J Med,1999,170(6):348-351.
|
|
[3] NAVANEETHAN U,NJEI B,VENKATESH PG,et al. Endoscopic ultrasound in the diagnosis of cholangiocarcinoma as the etiology of biliary strictures:A systematic review and meta-analysis[J].Gastroenterol Rep(Oxf),2015,3(3):209-215.
|
|
[4] LEE YN,MOON JH,CHOI HJ,et al. Diagnostic approach using ERCP-guided transpapillary forceps biopsy or EUSguided fine-needle aspiration biopsy according to the nature of stricture segment for patients with suspected malignant biliary stricture[J]. Cancer Med,2017,6(3):582-590.
|
|
[5] RANNEY N,PHADNIS M,TREVINO J,et al. Impact of biliary stents on EUS-guided FNA of pancreatic mass lesions[J].Gastrointest Endosc,2012,76(1):76-83.
|
|
[6] DRAGANOV PV,CHAUHAN S,WAGH MS,et al. Diagnostic accuracy of conventional and cholangioscopy-guided sampling of indeterminate biliary lesions at the time of ERCP:A prospective,long-term follow-up study[J]. Gastrointest Endosc,2012,75(2):347-353.
|
|
[7] TALREJA JP,SETHI A,JAMIDAR PA,et al. Interpretation of probe-based confocal laser endomicroscopy of indeterminate biliary strictures:Is there any interobserver agreement?[J].Dig Dis Sci,2012,57(12):3299-3302.
|
|
[8] HALTTUNEN J,MEISNER S,AABAKKEN L,et al. Difficult cannulation as defined by a prospective study of the Scandinavian Association for Digestive Endoscopy(SADE)in 907 ERCPs[J].Scand J Gastroenterol,2014,49(6):752-758.
|
|
[9] HU B,SUN B,CAI Q,et al. Asia-Pacific consensus guidelines for endoscopic management of benign biliary strictures[J]. Gastrointest Endosc,2017,86(1):44-58.
|
|
[10] KHAN MA,BARON TH,KAMAL F,et al. Efficacy of self-expandable metal stents in management of benign biliary strictures and comparison with multiple plastic stents:A metaanalysis[J]. Endoscopy,2017,49(7):682-694.
|
|
[11] van der GAAG NA,RAUWS EA,van EIJCK CH,et al. Preoperative biliary drainage for cancer of the head of the pancreas[J]. N Engl J Med,2010,362(2):129-137.
|
|
[12] TOL JA,VAN HOOFT JE,TIMMER R,et al. Metal or plastic stents for preoperative biliary drainage in resectable pancreatic cancer[J]. Gut,2016,65(12):1981-1987.
|
|
[13] SONG TJ,LEE JH,LEE SS,et al. Metal versus plastic stents for drainage of malignant biliary obstruction before primary surgical resection[J]. Gastrointest Endosc,2016,84(5):814-821.
|
|
[14] ISAYAMA H,KOMATSU Y,TSUJINO T,et al. A prospective randomised study of“covered”versus“uncovered”diamond stents for the management of distal malignant biliary obstruction[J]. Gut,2004,53(5):729-734.
|
|
[15] KROKIDIS M,FANELLI F,ORGERA G,et al. Percutaneous palliation of pancreatic head cancer:Randomized comparison of e PTFE/FEP-covered versus uncovered nitinol biliary stents[J]. Cardiovasc Intervent Radiol,2011,34(2):352-361.
|
|
[16] KITANO M,YAMASHITA Y,TANAKA K,et al. Covered selfexpandable metal stents with an anti-migration system improve patency duration without increased complications compared with uncovered stents for distal biliary obstruction caused by pancreatic carcinoma:A randomized multicenter trial[J]. Am J Gastroenterol,2013,108(11):1713-1722.
|
|
[17] NAKAI Y,ISAYAMA H,KAWABE T,et al. Efficacy and safety of metallic stents in patients with unresectable pancreatic cancer receiving gemcitabine[J]. Pancreas,2008,37(4):405-410.
|
|
[18] NAKAI Y,HAMADA T,ISAYAMA H,et al. Endoscopic management of combined malignant biliary and gastric outlet obstruction[J]. Dig Endosc,2017,29(1):16-25.
|
|
[19] HAMADA T,ISAYAMA H,NAKAI Y,et al. Transmural biliary drainage can be an alternative to transpapillary drainage in patients with an indwelling duodenal stent[J]. Dig Dis Sci,2014,59(8):1931-1938.
|
|
[20] OGURA T,CHIBA Y,MASUDA D,et al. Comparison of the clinical impact of endoscopic ultrasound-guided choledochoduodenostomy and hepaticogastrostomy for bile duct obstruction with duodenal obstruction[J]. Endoscopy,2016,48(2):156-163.
|
|
[21] KAHALEH M,MISHRA R,SHAMI VM,et al. Unresectable cholangiocarcinoma:Comparison of survival in biliary stenting alone versus stenting with photodynamic therapy[J]. Clin Gastroenterol Hepatol,2008,6(3):290-297.
|
|
[22] FIGUEROA-BAROJAS P,BAKHRU MR,HABIB NA,et al.Safety and efficacy of radiofrequency ablation in the management of unresectable bile duct and pancreatic cancer:A novel palliation technique[J]. J Oncol,2013,2013:910897.
|
|
[23] STRAND DS,COSGROVE ND,PATRIE JT,et al. ERCP-directed radiofrequency ablation and photodynamic therapy are associated with comparable survival in the treatment of unresectable cholangiocarcinoma[J]. Gastrointest Endosc,2014,80(5):794-804.
|
|
[24] DOLAK W,SCHREIBER F,SCHWAIGHOFER H,et al. Endoscopic radiofrequency ablation for malignant biliary obstruction:A nationwide retrospective study of 84 consecutive applications[J]. Surg Endosc,2014,28(3):854-860.
|
|
[25] YU H,MIAO L. Biliary stenting for cholangiocarcinoma:An update[J]. World Chin J Dig,2014,22(5):648-653.(in Chinese)于泓，缪林．胆管癌支架治疗的现状及进展[J]．世界华人消化杂志，2014,22(5):648-653.
|
|
[26] LEE DK,KIM HS,KIM KS,et al. The effect on porcine bile duct of a metallic stent covered with a paclitaxel-incorporated membrane[J]. Gastrointest Endosc,2005,61(2):296-301.
|
|
[27] KALINOWSKI M,ALFKE H,KLEB B,et al. Paclitaxel inhibits proliferation of cell lines responsible for metal stent obstruction:Possible topical application in malignant bile duct obstructions[J]. Invest Radiol,2002,37(7):399-404.
|
|
[28] SONG TJ,LEE SS,YUN SC,et al. Paclitaxel-eluting covered metal stents versus covered metal stents for distal malignant biliary obstruction:A prospective comparative pilot study[J]. Gastrointest Endosc,2011,73(4):727-733.
|
|
[29] KIM DH,JEONG YI,CHUNG CW,et al. Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells[J]. Int J Nanomedicine,2013,8:1697-1711.
|
DownLoad: